DCF — CORPORACION DEL CENTRO CARDIOVASCULA
Enterprise Value: $-167.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-167.6M
Enterprise Value
$-52.2M
PV of Cash Flows
$-115.4M
PV of Terminal Value
$-185.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $79.5M | $-10.9M | -14.0% | $-14.3M | $-13.0M |
| Year 2 | $81.9M | $-10.4M | -13.0% | $-13.9M | $-11.5M |
| Year 3 | $84.4M | $-9.9M | -12.0% | $-13.5M | $-10.1M |
| Year 4 | $86.9M | $-9.7M | -11.0% | $-13.4M | $-9.2M |
| Year 5 | $89.5M | $-9.8M | -11.0% | $-13.6M | $-8.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-167.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$77.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.14216649979810098
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5